REPORT ID 15978

Global Oncolytic Virus Market Professional Survey Report 2017

Publish Date
30-Nov-17
Pages
114
Format
Electronic (PDF)

This report studies Oncolytic Virus in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Merck
    Otsuka Pharmaceutical Co
    Pfizer
    Roche
    Cold Genesys
    Genelux
    Latima
    Neotropix
    Shanghai Sunway Biotech
    SillaJen
    Takara Bio
    Theravir

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    HSV-based Oncolytic Viruses
    Adenoviruses-based Oncolytic Viruses
    Vaccinia Virus-based Oncolytic Viruses
    Vesicular Stomatitis Virus-based Oncolytic Viruses
    Newcastle Disease Virus-based Oncolytic Viruses

By Application, the market can be split into
    Pharmaceutical
    Health Care
    Commerical

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Oncolytic Virus Market Professional Survey Report 2017
1 Industry Overview of Oncolytic Virus
    1.1 Definition and Specifications of Oncolytic Virus
        1.1.1 Definition of Oncolytic Virus
        1.1.2 Specifications of Oncolytic Virus
    1.2 Classification of Oncolytic Virus
        1.2.1 HSV-based Oncolytic Viruses
        1.2.2 Adenoviruses-based Oncolytic Viruses
        1.2.3 Vaccinia Virus-based Oncolytic Viruses
        1.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
        1.2.5 Newcastle Disease Virus-based Oncolytic Viruses
    1.3 Applications of Oncolytic Virus
        1.3.1 Pharmaceutical
        1.3.2 Health Care
        1.3.3 Commerical
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Oncolytic Virus
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Oncolytic Virus
    2.3 Manufacturing Process Analysis of Oncolytic Virus
    2.4 Industry Chain Structure of Oncolytic Virus

3 Technical Data and Manufacturing Plants Analysis of Oncolytic Virus
    3.1 Capacity and Commercial Production Date of Global Oncolytic Virus Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Oncolytic Virus Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Oncolytic Virus Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Oncolytic Virus Major Manufacturers in 2016

4 Global Oncolytic Virus Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Oncolytic Virus Capacity and Growth Rate Analysis
        4.2.2 2016 Oncolytic Virus Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Oncolytic Virus Sales and Growth Rate Analysis
        4.3.2 2016 Oncolytic Virus Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Oncolytic Virus Sales Price
        4.4.2 2016 Oncolytic Virus Sales Price Analysis (Company Segment)

5 Oncolytic Virus Regional Market Analysis
    5.1 North America Oncolytic Virus Market Analysis
        5.1.1 North America Oncolytic Virus Market Overview
        5.1.2 North America 2012-2017E Oncolytic Virus Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Oncolytic Virus Sales Price Analysis
        5.1.4 North America 2016 Oncolytic Virus Market Share Analysis
    5.2 China Oncolytic Virus Market Analysis
        5.2.1 China Oncolytic Virus Market Overview
        5.2.2 China 2012-2017E Oncolytic Virus Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Oncolytic Virus Sales Price Analysis
        5.2.4 China 2016 Oncolytic Virus Market Share Analysis
    5.3 Europe Oncolytic Virus Market Analysis
        5.3.1 Europe Oncolytic Virus Market Overview
        5.3.2 Europe 2012-2017E Oncolytic Virus Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Oncolytic Virus Sales Price Analysis
        5.3.4 Europe 2016 Oncolytic Virus Market Share Analysis
    5.4 Southeast Asia Oncolytic Virus Market Analysis
        5.4.1 Southeast Asia Oncolytic Virus Market Overview
        5.4.2 Southeast Asia 2012-2017E Oncolytic Virus Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Oncolytic Virus Sales Price Analysis
        5.4.4 Southeast Asia 2016 Oncolytic Virus Market Share Analysis
    5.5 Japan Oncolytic Virus Market Analysis
        5.5.1 Japan Oncolytic Virus Market Overview
        5.5.2 Japan 2012-2017E Oncolytic Virus Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Oncolytic Virus Sales Price Analysis
        5.5.4 Japan 2016 Oncolytic Virus Market Share Analysis
    5.6 India Oncolytic Virus Market Analysis
        5.6.1 India Oncolytic Virus Market Overview
        5.6.2 India 2012-2017E Oncolytic Virus Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Oncolytic Virus Sales Price Analysis
        5.6.4 India 2016 Oncolytic Virus Market Share Analysis

6 Global 2012-2017E Oncolytic Virus Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Oncolytic Virus Sales by Type
    6.2 Different Types of Oncolytic Virus Product Interview Price Analysis
    6.3 Different Types of Oncolytic Virus Product Driving Factors Analysis
        6.3.1 HSV-based Oncolytic Viruses of Oncolytic Virus Growth Driving Factor Analysis
        6.3.2 Adenoviruses-based Oncolytic Viruses of Oncolytic Virus Growth Driving Factor Analysis
        6.3.3 Vaccinia Virus-based Oncolytic Viruses of Oncolytic Virus Growth Driving Factor Analysis
        6.3.4 Vesicular Stomatitis Virus-based Oncolytic Viruses of Oncolytic Virus Growth Driving Factor Analysis
        6.3.5 Newcastle Disease Virus-based Oncolytic Viruses of Oncolytic Virus Growth Driving Factor Analysis

7 Global 2012-2017E Oncolytic Virus Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Oncolytic Virus Consumption by Application
    7.2 Different Application of Oncolytic Virus Product Interview Price Analysis
    7.3 Different Application of Oncolytic Virus Product Driving Factors Analysis
        7.3.1 Pharmaceutical of Oncolytic Virus Growth Driving Factor Analysis
        7.3.2 Health Care of Oncolytic Virus Growth Driving Factor Analysis
        7.3.3 Commerical of Oncolytic Virus Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Oncolytic Virus
    8.1 Merck
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Merck 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Merck 2016 Oncolytic Virus Business Region Distribution Analysis
    8.2 Otsuka Pharmaceutical Co
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Otsuka Pharmaceutical Co 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Otsuka Pharmaceutical Co 2016 Oncolytic Virus Business Region Distribution Analysis
    8.3 Pfizer
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Pfizer 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Pfizer 2016 Oncolytic Virus Business Region Distribution Analysis
    8.4 Roche
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Roche 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Roche 2016 Oncolytic Virus Business Region Distribution Analysis
    8.5 Cold Genesys
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Cold Genesys 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Cold Genesys 2016 Oncolytic Virus Business Region Distribution Analysis
    8.6 Genelux
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Genelux 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Genelux 2016 Oncolytic Virus Business Region Distribution Analysis
    8.7 Latima
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Latima 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Latima 2016 Oncolytic Virus Business Region Distribution Analysis
    8.8 Neotropix
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Neotropix 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Neotropix 2016 Oncolytic Virus Business Region Distribution Analysis
    8.9 Shanghai Sunway Biotech
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Shanghai Sunway Biotech 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Shanghai Sunway Biotech 2016 Oncolytic Virus Business Region Distribution Analysis
    8.10 SillaJen
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 SillaJen 2016 Oncolytic Virus Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 SillaJen 2016 Oncolytic Virus Business Region Distribution Analysis
    8.11 Takara Bio
    8.12 Theravir

9 Development Trend of Analysis of Oncolytic Virus Market
    9.1 Global Oncolytic Virus Market Trend Analysis
        9.1.1 Global 2017-2022 Oncolytic Virus Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Oncolytic Virus Sales Price Forecast
    9.2 Oncolytic Virus Regional Market Trend
        9.2.1 North America 2017-2022 Oncolytic Virus Consumption Forecast
        9.2.2 China 2017-2022 Oncolytic Virus Consumption Forecast
        9.2.3 Europe 2017-2022 Oncolytic Virus Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Oncolytic Virus Consumption Forecast
        9.2.5 Japan 2017-2022 Oncolytic Virus Consumption Forecast
        9.2.6 India 2017-2022 Oncolytic Virus Consumption Forecast
    9.3 Oncolytic Virus Market Trend (Product Type)
    9.4 Oncolytic Virus Market Trend (Application)

10 Oncolytic Virus Marketing Type Analysis
    10.1 Oncolytic Virus Regional Marketing Type Analysis
    10.2 Oncolytic Virus International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Oncolytic Virus by Region
    10.4 Oncolytic Virus Supply Chain Analysis

11 Consumers Analysis of Oncolytic Virus
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Oncolytic Virus Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source